Monthly Archives: November 2015

USP Seeking Comments on General Chapter Revisions. Deadline approaching!

The US Pharmacopeia (USP) is currently in the process of revising several general chapters that are important to the nuclear medicine community. The USP sets public standards that serve patients, academia, industry, regulators, healthcare professionals, and other stakeholders. As a … Continue reading

Posted in PET Drugs | Leave a comment

Reminder: Two-year post approval inspections

The Coalition would like to share some important reminders with PET Drug manufacturers that may be coming up on their two-year post approval inspection. Below is a list of items FDA inspectors recently asked for in one of the current … Continue reading

Posted in PET Drugs | Leave a comment